Urine Metabolites Associated with the Dietary Approaches to Stop Hypertension (DASH) Diet: Results from the DASH-Sodium Trial.

Pubmed ID: 33300290

Pubmed Central ID: PMC7967699

Journal: Molecular nutrition & food research

Publication Date: Feb. 1, 2021

Affiliation: Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, 21205, USA.

MeSH Terms: Humans, Male, Adult, Female, Adolescent, Middle Aged, Young Adult, Sodium, Dietary, Biomarkers, Dietary Approaches To Stop Hypertension, Urine

Grants: P30 DK072488, K01 DK107782, R03 DK128386, R21 HL143089, R56 HL153178, R01 HL153178

Authors: Appel LJ, Lichtenstein AH, Coresh J, Rebholz CM, Kim H, Wong KE

Cite As: Kim H, Lichtenstein AH, Wong KE, Appel LJ, Coresh J, Rebholz CM. Urine Metabolites Associated with the Dietary Approaches to Stop Hypertension (DASH) Diet: Results from the DASH-Sodium Trial. Mol Nutr Food Res 2021 Feb;65(3):e2000695. Epub 2020 Dec 28.

Studies:

Abstract

SCOPE: Serum metabolomic markers of the Dietary Approaches to Stop Hypertension (DASH) diet are previously reported. In an independent study, the similarity of urine metabolomic markers are investigated. METHODS AND RESULTS: In the DASH-Sodium trial, participants are randomly assigned to the DASH diet or control diet, and received three sodium interventions (high, intermediate, low) within each randomized diet group in random order for 30 days each. Urine samples are collected at the end of each intervention period and analyzed for 938 metabolites. Two comparisons are conducted: 1) DASH-high sodium (n = 199) versus control-high sodium (n = 193), and 2) DASH-low sodium (n = 196) versus control-high sodium. Significant metabolites identified using multivariable linear regression are compared and the top 10 influential metabolites identified using partial least-squares discriminant analysis to the results from the DASH trial. Nine out of 10 predictive metabolites of the DASH-high sodium and DASH-low sodium diets are identical. Most candidate biomarkers from the DASH trial replicated. N-methylproline, chiro-inositol, stachydrine, and theobromine replicated as influential metabolites of DASH diets. CONCLUSIONS: Candidate biomarkers of the DASH diet identified in serum replicated in urine. Replicated influential metabolites are likely to be objective biomarkers of the DASH diet.